Beta-Pro Management Team


Paul Manning President, Chief Executive Officer	Cindy Barber Chief Operating Officer, Beta-Pro	Ken Brayman Scientific Advisor, Beta-Pro

The Leadership of Beta-Pro Believes in Cellular Therapies

The management team of Beta-Pro believes cellular therapies are essential to the future success of regenerative medicine. We are on a mission to help cure diabetes by supplying customized, in vitro islet cellservices to leading scientific, medical, research, and pharmaceutical communities throughout the world.

Our team has a combined, proven track record in consumer, pharmaceutical, biotechnology, and health sectors. Beta-Pro is also counseled by a scientific advisor who directs the renal, pancreas, and human islet cell transplant programs at the University of Virginia Medical Center.

Beta-Pro's Clinical-grade Cellular Products are Manufactured in a "Clean Room"

The University of Virginia operates an FDA-approved, Current Good Manufacturing Practices (cGMP) “clean room” facility that isolates our clinical-grade islet cells. Thanks to a collaborative arrangement with the institution, we distribute islets to different organizations.

Home Contact Us Site Map

Beta-Pro (www.betaprollc.com) is dedicated to compliance with all existing federal, state, and institutional requirements pertaining to the collection and use of cells. Strict procedures are in place to protect the privacy and confidentiality of all volunteer donors, including coding procedures for cells and associated clinical information, so that a donor’s identity is inaccessible to Beta-Pro and researchers.